{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:45:30Z","timestamp":1782899130209,"version":"3.54.5"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejim.2026.106762","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T04:50:04Z","timestamp":1770785404000},"page":"106762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Refining checklist-based screening for transthyretin cardiac amyloidosis: Methodological and pathophysiological considerations"],"prefix":"10.1016","volume":"149","author":[{"given":"Li","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6634-6627","authenticated-orcid":false,"given":"Shu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4200-7211","authenticated-orcid":false,"given":"Fengxia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.106762_bib0001","article-title":"Impact of a checklist-based strategy for cardiac amyloidosis screening on diagnosis rates in heart failure patients (CHECKAMIC Study)","author":"P\u00e9rez-Nieva","year":"2025","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2026.106762_bib0002","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2026.106762_bib0003","article-title":"Accuracy of devereux and teichholz formulas for left ventricular mass calculation in different geometric patterns: comparison with cardiac magnetic resonance imaging","volume":"13","author":"Sveric","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2026.106762_bib0004","first-page":"268","article-title":"Clinical phenotype and prognostic significance of frailty in transthyretin cardiac amyloidosis","volume":"7","author":"Fumagalli","year":"2025","journal-title":"Cardio Oncol"},{"key":"10.1016\/j.ejim.2026.106762_bib0005","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ejhf.2824","article-title":"Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis","volume":"25","author":"Aimo","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2026.106762_bib0006","doi-asserted-by":"crossref","first-page":"qyaf148","DOI":"10.1093\/ehjimp\/qyaf148","article-title":"RWT\/SaVR ratio displays strong diagnostic performance to identify transthyretin amyloid cardiomyopathy in females: implications for sex-specific echocardiographic thresholds","volume":"3","author":"Lindqvist","year":"2025","journal-title":"Eur Heart J-Imaging Methods Pract"},{"key":"10.1016\/j.ejim.2026.106762_bib0007","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1002\/ejhf.2674","article-title":"Unravelling the role of sex in the pathophysiology, phenotypic expression and diagnosis of cardiac amyloidosis","volume":"24","author":"Rapezzi","year":"2022","journal-title":"Eur J Heart Fail"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:46:09Z","timestamp":1782895569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526000671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":7,"alternative-id":["S0953620526000671"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106762","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refining checklist-based screening for transthyretin cardiac amyloidosis: Methodological and pathophysiological considerations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106762"}}